| 排名 | 分析师 | 机构 | 行业 | 年度收益率 | 6个月收益率 | 3个月收益率 | 正收益比例 | 成分股数量 | 历史最大跌幅 | 更新日期 |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 胡晨曦 | 长城国瑞证券 | 医药生物 | 31.57% | 46.32% | 29.27% | 12.50% | 1 | -27.10% | 2025-03-28 |
| 2 | 阳景 | 浦银国际证券 | 医药生物 | 31.47% | 40.56% | 11.25% | 100.00% | 4 | 0.00% | 2025-06-04 |
| 3 | 韩世通 | 中信证券 | 医药生物 | 31.46% | 34.74% | 16.10% | -2.04% | 6 | -63.25% | 2025-07-04 |
| 4 | 阳景 | 浦银国际证券 | 医药生物 | 31.45% | 28.96% | 4.07% | 100.00% | 4 | 0.00% | 2025-06-30 |
| 5 | 胡晨曦 | 长城国瑞证券 | 医药生物 | 31.44% | 46.17% | 29.13% | 12.50% | 1 | -27.10% | 2025-03-27 |
| 6 | 万鹏辉 | 国海证券 | 医药生物 | 31.43% | 31.33% | 19.96% | 50.00% | 5 | -3.00% | 2025-07-23 |
| 7 | 刘浩 | 华创证券 | 医药生物 | 31.42% | 27.84% | 30.09% | 29.41% | 2 | -47.33% | 2025-04-25 |
| 8 | 杨松 | 天风证券 | 医药生物 | 31.39% | 35.88% | 26.53% | -40.89% | 19 | -72.65% | 2025-07-16 |
| 9 | 仰佳佳 | 申万宏源 | 医药生物 | 31.33% | 37.71% | 31.24% | 23.08% | 1 | -37.64% | 2025-04-29 |
| 10 | 华挺 | 财通证券 | 医药生物 | 31.31% | 26.70% | 17.14% | -6.67% | 4 | -50.33% | 2025-06-16 |
| 11 | 吴春红 | 江海证券 | 医药生物 | 31.30% | 12.12% | 23.18% | 27.27% | 7 | -25.67% | 2025-05-30 |
| 12 | 吴春红 | 江海证券 | 医药生物 | 31.29% | 19.15% | 25.90% | 27.27% | 7 | -25.67% | 2025-05-19 |
| 13 | 袁聪敏 | 中信证券 | 医药生物 | 31.29% | 24.94% | 33.69% | 100.00% | 5 | 0.00% | 2025-04-03 |
| 14 | 华挺 | 财通证券 | 医药生物 | 31.25% | 25.42% | 16.65% | -6.67% | 4 | -50.33% | 2025-06-10 |
| 15 | 华挺 | 财通证券 | 医药生物 | 31.23% | 25.47% | 17.08% | -6.67% | 4 | -50.33% | 2025-06-09 |
| 16 | 仰佳佳 | 申万宏源 | 医药生物 | 31.17% | 31.12% | 23.05% | 23.08% | 1 | -37.64% | 2025-06-04 |
| 17 | 张林晚 | 上海证券 | 医药生物 | 31.17% | 31.17% | 18.06% | -100.00% | 1 | -18.93% | 2025-07-01 |
| 18 | 张林晚 | 上海证券 | 医药生物 | 31.17% | 33.41% | 32.78% | -100.00% | 1 | -18.93% | 2025-07-07 |
| 19 | 任晓帆 | 东海证券 | 医药生物 | 31.17% | 29.12% | 33.54% | 0.00% | 2 | -17.50% | 2025-07-17 |
| 20 | 武煜 | 招银国际 | 医药生物 | 31.12% | 21.10% | 15.17% | -33.33% | 1 | -16.66% | 2025-06-09 |